Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes.
de Swart, Louise
Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes. [electronic resource] - Haematologica 01 2018 - 69-79 p. digital
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
1592-8721
10.3324/haematol.2017.171884 doi
Adult
Aged
Aged, 80 and over
Biomarkers
Blood Transfusion--methods
Erythropoietin--therapeutic use
Female
Humans
Iron--metabolism
Iron Overload--etiology
Male
Middle Aged
Myelodysplastic Syndromes--blood
Prognosis
Proportional Hazards Models
Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes. [electronic resource] - Haematologica 01 2018 - 69-79 p. digital
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
1592-8721
10.3324/haematol.2017.171884 doi
Adult
Aged
Aged, 80 and over
Biomarkers
Blood Transfusion--methods
Erythropoietin--therapeutic use
Female
Humans
Iron--metabolism
Iron Overload--etiology
Male
Middle Aged
Myelodysplastic Syndromes--blood
Prognosis
Proportional Hazards Models